231 related articles for article (PubMed ID: 24065591)
1. PLGA/liposome hybrid nanoparticles for short-chain ceramide delivery.
Zou P; Stern ST; Sun D
Pharm Res; 2014 Mar; 31(3):684-93. PubMed ID: 24065591
[TBL] [Abstract][Full Text] [Related]
2. PLGA nanoparticles introduction into mitoxantrone-loaded ultrasound-responsive liposomes: In vitro and in vivo investigations.
Xin Y; Qi Q; Mao Z; Zhan X
Int J Pharm; 2017 Aug; 528(1-2):47-54. PubMed ID: 28559216
[TBL] [Abstract][Full Text] [Related]
3. Thermodynamic Insights and Conceptual Design of Skin-Sensitive Chitosan Coated Ceramide/PLGA Nanodrug for Regeneration of Stratum Corneum on Atopic Dermatitis.
Jung SM; Yoon GH; Lee HC; Jung MH; Yu SI; Yeon SJ; Min SK; Kwon YS; Hwang JH; Shin HS
Sci Rep; 2015 Dec; 5():18089. PubMed ID: 26666701
[TBL] [Abstract][Full Text] [Related]
4. Rapid distribution of liposomal short-chain ceramide in vitro and in vivo.
Zolnik BS; Stern ST; Kaiser JM; Heakal Y; Clogston JD; Kester M; McNeil SE
Drug Metab Dispos; 2008 Aug; 36(8):1709-15. PubMed ID: 18490436
[TBL] [Abstract][Full Text] [Related]
5. PLGA/polymeric liposome for targeted drug and gene co-delivery.
Wang H; Zhao P; Su W; Wang S; Liao Z; Niu R; Chang J
Biomaterials; 2010 Nov; 31(33):8741-8. PubMed ID: 20727587
[TBL] [Abstract][Full Text] [Related]
6. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery.
Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD
Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine hydrochloride-loaded liposomes and nanoparticles: comparison of encapsulation efficiency, drug release, particle size, and cytotoxicity.
Yalcin TE; Ilbasmis-Tamer S; Ibisoglu B; Özdemir A; Ark M; Takka S
Pharm Dev Technol; 2018 Jan; 23(1):76-86. PubMed ID: 28724327
[TBL] [Abstract][Full Text] [Related]
8. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.
Ma W; Chen M; Kaushal S; McElroy M; Zhang Y; Ozkan C; Bouvet M; Kruse C; Grotjahn D; Ichim T; Minev B
Int J Nanomedicine; 2012; 7():1475-87. PubMed ID: 22619507
[TBL] [Abstract][Full Text] [Related]
9. Inducing Controlled Release and Increased Tumor-Targeted Delivery of Chlorambucil via Albumin/Liposome Hybrid Nanoparticles.
Zhang Q; Zhang L; Li Z; Xie X; Gao X; Xu X
AAPS PharmSciTech; 2017 Nov; 18(8):2977-2986. PubMed ID: 28477146
[TBL] [Abstract][Full Text] [Related]
10. Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells.
Stover T; Kester M
J Pharmacol Exp Ther; 2003 Nov; 307(2):468-75. PubMed ID: 12975495
[TBL] [Abstract][Full Text] [Related]
11. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X
J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752
[TBL] [Abstract][Full Text] [Related]
12. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
[TBL] [Abstract][Full Text] [Related]
13. Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration.
Miyazawa T; Nakagawa K; Harigae T; Onuma R; Kimura F; Fujii T; Miyazawa T
Int J Nanomedicine; 2015; 10():7223-30. PubMed ID: 26664113
[TBL] [Abstract][Full Text] [Related]
14. Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo.
Qiao C; Zhang K; Jin H; Miao L; Shi C; Liu X; Yuan A; Liu J; Li D; Zheng C; Zhang G; Li X; Yang B; Sun H
Int J Nanomedicine; 2013; 8():2985-95. PubMed ID: 23990717
[TBL] [Abstract][Full Text] [Related]
15. Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma.
Liu J; Boonkaew B; Arora J; Mandava SH; Maddox MM; Chava S; Callaghan C; He J; Dash S; John VT; Lee BR
J Pharm Sci; 2015 Mar; 104(3):1187-96. PubMed ID: 25573425
[TBL] [Abstract][Full Text] [Related]
16. Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.
Xu P; Gullotti E; Tong L; Highley CB; Errabelli DR; Hasan T; Cheng JX; Kohane DS; Yeo Y
Mol Pharm; 2009; 6(1):190-201. PubMed ID: 19035785
[TBL] [Abstract][Full Text] [Related]
17. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
Li X; Xu Y; Chen G; Wei P; Ping Q
Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
[TBL] [Abstract][Full Text] [Related]
18. Transfer of lipophilic markers from PLGA and polystyrene nanoparticles to caco-2 monolayers mimics particle uptake.
Pietzonka P; Rothen-Rutishauser B; Langguth P; Wunderli-Allenspach H; Walter E; Merkle HP
Pharm Res; 2002 May; 19(5):595-601. PubMed ID: 12069160
[TBL] [Abstract][Full Text] [Related]
19. Sinefungin-PLGA nanoparticles: drug loading, characterization, in vitro drug release and in vivo studies.
Kalimouttou S; Skiba M; Bon P; Déchelotte P; Arnaud P; Lahiani-Skiba M
J Nanosci Nanotechnol; 2009 Jan; 9(1):150-8. PubMed ID: 19441289
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of acetyl curcumin-loaded core/shell liposome nanoparticles via an electrospray process for drug delivery, and theranostic applications.
Reddy AS; Lakshmi BA; Kim S; Kim J
Eur J Pharm Biopharm; 2019 Sep; 142():518-530. PubMed ID: 31365879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]